PHARMACIA AND UPJOHN FDA Approval NDA 020874

NDA 020874

PHARMACIA AND UPJOHN

FDA Drug Application

Application #020874

Documents

Letter2000-10-05
Label2000-10-05
Review2005-04-11

Application Sponsors

NDA 020874PHARMACIA AND UPJOHN

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INTRAMUSCULAR5MG/0.5ML;25MG/0.5ML0LUNELLEESTRADIOL CYPIONATE; MEDROXYPROGESTERONE ACETATE

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP2000-10-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2002-04-26STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0

CDER Filings

PHARMACIA AND UPJOHN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20874
            [companyName] => PHARMACIA AND UPJOHN
            [docInserts] => ["",""]
            [products] => [{"drugName":"LUNELLE","activeIngredients":"ESTRADIOL CYPIONATE; MEDROXYPROGESTERONE ACETATE","strength":"5MG\/0.5ML;25MG\/0.5ML","dosageForm":"INJECTABLE;INTRAMUSCULAR","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"10\/05\/2000","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2000\\\/20874lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"LUNELLE","submission":"ESTRADIOL CYPIONATE; MEDROXYPROGESTERONE ACETATE","actionType":"5MG\/0.5ML;25MG\/0.5ML","submissionClassification":"INJECTABLE;INTRAMUSCULAR","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2000-10-05
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.